secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eledon Pharmaceuticals, Inc. (ELDN)
CIK:        0001404281
Form:       8-K
Filed at:   2021-07-02T23:59:59+00:00
Accession:  0001564590-21-035584
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Eledon appoints Jan Hillson, M.D. as independent director; grants option for 40,000 shares
--------------------------------------------------------------------------------

- Jan Hillson, M.D. appointed to Eledon board effective July 1, 2021; qualifies as independent under Nasdaq rules.
- Received option to buy 40,000 shares at $7.68 per share; vests 20,000 on first anniversary, 20,000 on second anniversary.
- Dr. Hillson will enter Eledon's standard indemnification agreement; no family relationships with officers/directors.
- No arrangements or understandings with any other person regarding her appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404281/000156459021035584/0001564590-21-035584-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404281/000156459021035584/eldn-8k_20210701.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-035584

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer